You may be wondering, "How long do I have to take testosterone replacement therapy?" If you're over 30, you already know that it's normal for testosterone levels to decrease after age 30. However, low testosterone can increase your risk of heart disease and diabetes. Even if your symptoms aren't immediately noticeable go to Regenics â†’, it's still worth addressing low testosterone as early as possible.
Although testosterone replacement therapy is effective at treating hypogonadism, there are several side effects to consider. Long-term use of the treatment can lead to increased risk of heart attacks and strokes. While it is not officially recommended by the NHS, it is used to treat men who do not produce enough testosterone on their own.
Treatment involves the administration of testosterone in the form of injections or subcutaneous pellets. These are placed under the skin at specific intervals. The dosage is increased as necessary, and testosterone levels will be monitored regularly. The dosage may be adjusted every three to six months. The doctor may also measure red blood cells to ensure that the testosterone levels remain optimal.
Reduces risk of heart disease
There are several studies that support a reduction in the risk of heart disease associated with testosterone replacement therapy. These studies lasted nine to five months, and were conducted with a control group to assess whether testosterone treatment reduced the risk of cardiovascular events. While the primary endpoint of the studies was not heart disease, it was noted that testosterone treatment decreased the risk of coronary heart disease, myocardial infarction, and stroke.
In one study, researchers measured the function of the arteries using a method that measures the amount of blood flowing through them. They also assessed the inner lining of the arteries to assess their ability to dilate. Both testosterone therapy and exercise training improved the condition of the arteries.
Reduces risk of diabetes
A recent study has revealed that taking testosterone replacement therapy can reduce the risk of diabetes in obese hypogonadal males. Studies have shown that taking testosterone reduces blood glucose levels, HbA1c levels, and inflammation. Other benefits of testosterone therapy include improved cardiovascular health, improved vascular function, and increased lean muscle mass.
In one study, men taking testosterone replacement therapy had lower all-cause mortality than those who did not take the drug. This was true both for men and women. Another study found that testosterone replacement therapy may reverse the progression of type 2 diabetes. However, the findings are not conclusive.
Two recent studies have shown that taking TRT for 12 months reduces the risk of diabetes. In the TIMES-2 study, participants improved their insulin sensitivity and reduced their total body fat. However, the study had a significant drop-out rate.
Improves sex life
When taking testosterone replacement therapy, there are many benefits, including increased desire for sex and improved performance during sexual intercourse. It can also lead to increased intimacy and affection with your partner. While testosterone replacement therapy is relatively safe and has few side effects, you should consult with your doctor before beginning any treatment.
Studies have shown that testosterone replacement therapy can improve libido and erectile function in hypogonadal men. The largest placebo-controlled multicenter study to date on the treatment found that it improved libido and erectility in hypogonadal men. The study also found no new side effects.
Testosterone can also help to reverse fatigue. The hormone is also known to have antidepressant properties, which can help fight depression. In a recent study, men who took testosterone replacement therapy showed significant improvements in their depression scores. This was especially noticeable in men who had recently experienced mood changes.
Reduces body fat
A recent study found that taking testosterone replacement therapy reduces body fat in men. The researchers studied 49 men who took a 1,000 mg intramuscular testosterone undecanoate injection every ten weeks. The other 51 men took a placebo. By the end of the study, both groups had lost an average of 11 kg (24.2 lb), but the men in the testosterone group lost more fat than the placebo group. They also lost less lean muscle mass than the placebo group.
Researchers found that testosterone replacement therapy reduced body fat in obese middle-aged men. This was due in part to the reduction of estrogen levels in the body. In addition, it increased circulating testosterone in the men. Although the study is still in its early stages, this treatment may help obese middle-aged men lose body fat without losing muscle mass.